Yale Study Identifies New Drug Targets for Aggressive Leukemia

A new study from Yale researchers has identified a new class of drug targets for aggressive leukemia, offering a promising approach for future treatments.

The research was supported in part by Rally Foundation for Childhood Cancer Research, alongside several national organizations and institutions, helping advance discoveries like this. Read more.
(https://medicine.yale.edu/news-article/yale-study-identifies-a-new-class-of-drug-targets-for-aggressive-leukemia/)